Percheron Therapeutics LimitedASX: PER

ATL1102 DMD Clinical Trial Application Submitted in Europe

Jul 13, 2022 at 3:45 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment